Skip to main content

Published locations for FDA gives orphan drug designation to BIV201 for ascites treatment

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA gives orphan drug designation to BIV201 for ascites treatment

User login

  • Reset your password
  • /content/fda-gives-orphan-drug-designation-biv201-ascites-treatment
  • /familypracticenews/article/113814/critical-care/fda-gives-orphan-drug-designation-biv201-ascites
  • /gihepnews/article/113814/critical-care/fda-gives-orphan-drug-designation-biv201-ascites-treatment
  • /ehospitalistnews/article/113814/critical-care/fda-gives-orphan-drug-designation-biv201-ascites
  • /internalmedicinenews/article/113814/critical-care/fda-gives-orphan-drug-designation-biv201-ascites
  • /internalmedicine/article/113814/critical-care/fda-gives-orphan-drug-designation-biv201-ascites
  • /familymedicine/article/113814/critical-care/fda-gives-orphan-drug-designation-biv201-ascites